From the Division of Renal Diseases and Hypertension, Department of Medicine (S.L., K.A.S., M.F.M., R.M.T., A.J.J., S.B.F., R.A.N., M.C.M.W.-E.), University of Colorado, Anschutz Medical Campus, Aurora.
School of Medicine, Consortium for Fibrosis Research and Translation (S.B.F., R.A.N., M.C.M.W.-E.), University of Colorado, Anschutz Medical Campus, Aurora.
Arterioscler Thromb Vasc Biol. 2020 Feb;40(2):394-403. doi: 10.1161/ATVBAHA.119.313757. Epub 2019 Dec 19.
Pathological vascular remodeling and excessive perivascular fibrosis are major contributors to reduced vessel compliance that exacerbates cardiovascular diseases, for instance, promoting clinically relevant myocardial remodeling. Inflammation plays a significant role in both pathological vascular remodeling and fibrosis. We previously demonstrated that smooth muscle cell-specific PTEN depletion promotes significant vascular fibrosis and accumulation of inflammatory cells. In the current study, we aimed to determine the beneficial role of systemic PTEN elevation on Ang II (angiotensin II)-induced vascular fibrosis and remodeling. Approach and Results: Transgenic mice carrying additional copies of the wild-type gene (super PTEN [sPTEN]) and WT littermates were subjected to Ang II or saline infusion for 14 or 28 days. Compared with WT, Ang II-induced vascular fibrosis was significantly blunted in sPTEN mice, as shown by histochemical stainings and label-free second harmonic generation imaging. The protection against Ang II was recapitulated in sPTEN mice bearing WT bone marrow but not in WT mice reconstituted with sPTEN bone marrow. Ang II-induced elevation of profibrotic and proinflammatory gene expression observed in WT mice was blocked in aortic tissue of sPTEN mice. Immunofluorescent staining and flow cytometry both indicated that perivascular infiltration of T cells and macrophages was significantly inhibited in sPTEN mice. In vitro induction of PTEN expression suppressed Ang II-induced Ccl2 expression in vascular smooth muscle cells.
Systemic PTEN elevation mediates protection against Ang II-induced vascular inflammation and fibrosis predominantly through effects in resident vascular cells. Our data highly support that pharmacological upregulation of PTEN could be a novel and viable approach for the treatment of pathological vascular fibrosis.
病理性血管重构和血管周围过度纤维化是导致血管顺应性降低的主要因素,这会加剧心血管疾病,例如促进临床相关的心肌重构。炎症在病理性血管重构和纤维化中都起着重要作用。我们之前的研究表明,平滑肌细胞特异性 PTEN 缺失会促进显著的血管纤维化和炎症细胞的积累。在本研究中,我们旨在确定全身性 PTEN 升高对 Ang II(血管紧张素 II)诱导的血管纤维化和重构的有益作用。
携带额外野生型 基因(超 PTEN[sPTEN])拷贝的转基因小鼠和 WT 同窝仔鼠接受 Ang II 或盐水输注 14 或 28 天。与 WT 相比,Ang II 诱导的血管纤维化在 sPTEN 小鼠中明显减弱,这通过组织化学染色和无标记二次谐波成像显示。在携带 WT 骨髓的 sPTEN 小鼠中再现了对 Ang II 的保护作用,但在 WT 小鼠中用 sPTEN 骨髓重建则没有。在 WT 小鼠中观察到的 Ang II 诱导的促纤维化和促炎基因表达的升高在 sPTEN 小鼠的主动脉组织中被阻断。免疫荧光染色和流式细胞术均表明,sPTEN 小鼠的血管周围浸润的 T 细胞和巨噬细胞明显减少。体外诱导 PTEN 表达可抑制血管平滑肌细胞中 Ang II 诱导的 Ccl2 表达。
全身性 PTEN 升高通过对驻留血管细胞的作用介导对 Ang II 诱导的血管炎症和纤维化的保护作用。我们的数据高度支持,PTEN 的药理学上调可能是治疗病理性血管纤维化的一种新的可行方法。